Cannabics Pharmaceuticals Announces Positive Results for Pilot Study on Treatment of Cancer Anorexia-Cachexia Syndrome (CACS)

MMJ reduces opioid use

Preliminary findings showed +80% of patients had increase in appetite and 60% +10% weight increase ISRAEL & MARYLAND: Cannabics Pharmaceuticals, a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced the results of its pilot study to test the efficacy of Cannabics capsules for the treatment of cancer anorexia-cachexia syndrome (CACS) in advanced Read the full article…

Yom Chai Forms Strategic Partnership With Israeli Research and Development Company Kaneh-B

research

Partnership Will Conduct Scientific Clinical Trials On ADHD; Distribute Approved European Dermal Products ISRAEL:  Yom Chai has entered into a strategic partnership with Kaneh-B to co-found the development and clinical validation of a range of cannabis based ADHD products. Yom Chai’s objective is to conduct scientific trials in Israel utilizing various Cannabinoid and Terpene profiles with the goal of Read the full article…

Father of THC Dr. Raphael Mechoulam Keynotes CannX Oct 14-16 In Tel Aviv

Dr Raphael Machoulam

ISRAEL: Dr. Raphael Mechoulam, Professor of Medicinal Chemistry at The Hebrew University of Jerusalem, Israel, and the man credited with first discovering and isolating THC will keynote the 3rd International Medical Cannabis Conference (CannX), October 14-16th in Tel Aviv. Speaking on The Plant Cannabinoids And The Endocannabinoid System — An Overview Of Research Over Five Decades, Dr. Mechoulam will set Read the full article…

Fibromyalgia Patients Report Subjective Benefits From Cannabis

Pain relief was reported by 94 percent of cannabis consumers

ISRAEL: Patients suffering from fibromyalgia frequently use cannabis to treat chronic pain and other symptoms of the disease, according to data published in the journal Pain Research and Treatment. Israeli researchers surveyed over 2,700 fibromyalgia patients. Of those who responded to the questionnaire, 84 percent reported consuming cannabis. “Pain relief was reported by 94 percent of cannabis consumers, while 93 percent Read the full article…

Yom Chai Signs MOU With Way Of Life Medical Cannabis For Israel, Portugal And Malta.

Yom Chai signs MoU with Way of Life Medical Cannabis

ISRAEL: New medical cannabis company Yom Chai has entered into a Memorandum of Understanding (“MOU”) with Way of Life Medical Cannabis to breed proprietary genetics, formulate, manufacture and distribute a wide range of Cannabis-based products to treat various medical conditions. Yom Chai’s objective is to conduct scientific trials in Israel utilizing various Cannabinoid and Terpene Read the full article…

iCAN Signs MoU With Yom Chai for Crohn’s Disease And Autism

the wide world of weed

ISRAEL: The Directors of Ananda Developments have announced that investee company iCAN has signed an MoU with a new Israeli Medical Cannabis company Yom Chai to develop and clinically validate cannabis based treatments for Crohn’s Disease, Autism and other neurodevelopmental, neurodegenerative and gastrointestinal diseases. Yom Chai has deep experience in the international medical cannabis market Read the full article…

Israeli Cannabis Producer Tefen Concludes $23 Million Local Sales Deal

Yom Chai signs MoU with Way of Life Medical Cannabis

Countries Around the World Seek to Import Israeli Cannabis Products but Cannot Due to Israel Government Bureaucracy Preventing Approval: “The Israeli Export Window is Closing.” ISRAEL: Tefen, a new Israeli licensed medical-grade cannabis producer has recently concluded two deals valued at approximately $23 million to supply 14 tons of medical-grade cannabis to a large Israeli processor and distributor Read the full article…

Study: Oral THC Safe And Effective At Treating Symptoms Of Anorexia

"The impact of delta-9-THC on the psychological symptoms of anorexia nervosa: A pilot study," appears in The Israeli Journal of Psychiatry and Related Sciences.

ISRAEL:  The daily administration of low doses of oral THC is associated with treating various symptoms associated with anorexia nervosa, according to clinical trial data published in The Israeli Journal of Psychiatry and Related Sciences. Investigators with Hebrew University in Jerusalem and the Eating Disorders Institution at the University of Haifa assessed the daily use of up to Read the full article…

Study: CBD Therapy Improves Autistic Symptoms

CBD is a major part of the growing legal cannabis market

ISRAEL: The adjunctive use of high CBD oral extracts is associated with improvements in symptom management in children with autism-related behavioral issues, according to clinical data published online ahead of print in the journal Neurology. Israeli researchers assessed the use of oral extracts containing a 20 to 1 ratio of CBD to THC in 60 adolescents with autism spectrum Read the full article…

Study: CBD Extracts Significantly Reduced Seizure Frequency In Children With Refractory Epilepsy

Israeli researchers assessed the sustained daily use of extracted CBD oils in a cohort of young patients with treatment resistant epilepsy.

ISRAEL: The adjunctive use of CBD extracts is safe and effective in adolescent patients with refractory epilepsy, according to clinical data published online ahead of print in the journal Brain & Development. Israeli researchers assessed the sustained daily use of extracted CBD oils in a cohort of young patients with treatment resistant epilepsy. Thirty-five percent of participants experienced a Read the full article…